Diane F. Jelinek

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

Robert A. Kyle, Ellen D. Remstein, Terry M. Therneau et al. · New England Journal of Medicine · 2007 · 919 citations · Full text

Medicine, Hematology, Pathology +17

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Tait D. Shanafelt, Xin V. Wang, Neil E. Kay et al. · New England Journal of Medicine · 2019 · 738 citations · Full text

Medicine, Immunology, Oncology +16

Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival

Anne J. Novak, Jaime Darce, Bonnie K. Arendt et al. · Blood · 2003 · 557 citations · Full text

Medicine, Hematology, Oncology +10

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Angela Dispenzieri, Robert A. Kyle, Jerry A. Katzmann et al. · Blood · 2007 · 427 citations · Full text

Medicine, Immunology, Oncology +13

Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis.

Diane F. Jelinek, S Andersson, Clive A. Slaughter et al. · Journal of Biological Chemistry · 1990 · 367 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17